Levy Raphi: insider trades.
Levy Raphi reported 11 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($823K), across 1 company.
- Transactions
- 11
- Purchases (P)
- 0
- Sales (S)
- 6
- Companies
- 1
- Name as filed
- Levy Raphi
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Alpha Tau Medical Ltd. (DRTS) | Officer · Chief Financial Officer | 11 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-21 | Alpha Tau Medical Ltd. | S | 2,871 | $15 | 90,180 | Form 4 |
| 2026-08-21 | Alpha Tau Medical Ltd. | M | 2,871 | $2.98 | 93,051 | Form 4 |
| 2026-08-11 | Alpha Tau Medical Ltd. | S | 17,730 | $14 | 90,180 | Form 4 |
| 2026-08-11 | Alpha Tau Medical Ltd. | M | 17,730 | $2.98 | 107,910 | Form 4 |
| 2026-07-06 | Alpha Tau Medical Ltd. | S | 2,270 | $14 | 90,180 | Form 4 |
| 2026-07-06 | Alpha Tau Medical Ltd. | M | 2,270 | $2.98 | 92,450 | Form 4 |
| 2026-07-02 | Alpha Tau Medical Ltd. | S | 17,873 | $13 | 90,180 | Form 4 |
| 2026-07-02 | Alpha Tau Medical Ltd. | M | 17,873 | $2.98 | 108,053 | Form 4 |
| 2026-07-01 | Alpha Tau Medical Ltd. | M | 2,127 | $2.98 | 92,307 | Form 4 |
| 2026-07-01 | Alpha Tau Medical Ltd. | S | 2,127 | $13.02 | 90,180 | Form 4 |
| 2026-06-30 | Alpha Tau Medical Ltd. | S | 20,000 | $12 | 90,180 | Form 4 |
Questions
What stock did Levy Raphi buy or sell?
Levy Raphi reported 11 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($823K), across 1 company.
Is Levy Raphi the same person as other filers with this name?
This page covers SEC CIK 1968095 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/levy-raphi-1968095.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.